<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://comparerx.org/news/glp1-reduces-tuberculosis-infection-risk</loc>
    <news:news>
      <news:publication>
        <news:name>CompareRx.org</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T00:16:08.271Z</news:publication_date>
      <news:title>GLP-1s cut tuberculosis and infection risks — expanding the therapy’s clinical value for cash buyers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://comparerx.org/news/youth-glp1-study-links-treatment-heightened-gallbladder-risks</loc>
    <news:news>
      <news:publication>
        <news:name>CompareRx.org</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-09-01T00:15:41.814Z</news:publication_date>
      <news:title>Youth GLP-1 study links treatment to 62% higher gallbladder risk — what the safety data means for younger buyers</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://comparerx.org/news/cvs-health-survey-employers-overhaul-glp1-benefits</loc>
    <news:news>
      <news:publication>
        <news:name>CompareRx.org</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-08-31T16:15:28.335Z</news:publication_date>
      <news:title>CVS Health survey reveals employers overhaul benefits as GLP-1 costs surge — driving buyers to telehealth cash options</news:title>
    </news:news>
  </url>
</urlset>